CGH2466, a Combined Adenosine Receptor Antagonist, P38 Mitogen-Activated Protein Kinase and Phosphodiesterase Type 4 Inhibitor With Potentin Vitroandin Vivoanti-Inflammatory Activities

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0706132
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

LY2228820 Dimesylate, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formationin Vitroandin Vivo

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2014English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2012English

Metabolism of a Novel Skepinone L-Like P38 Mitogen-Activated Protein Kinase Inhibitor

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2014English

Human P38 Mitogen-Activated Protein Kinase Inhibitor Drugs Inhibit Plasmodium Falciparum Replication

Experimental Parasitology
MedicineParasitologyInfectious DiseasesImmunology
2011English

MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2012English

Activation of P38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization

Traffic
BiochemistryGeneticsCell BiologyMolecular BiologyStructural Biology
2006English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14); X-Box Binding Protein 1 (XBP1)

Science-Business eXchange
2011English

Cutaneous P38 Mitogen-Activated Protein Kinase Activation Triggers Psoriatic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy